Components of NOTCH Signaling for Uterine Cancer Patients’ Prognosis

Table 1

Clinical-pathological data of patients participating in the study.

Clinical-pathological characteristics	Number of patients (%)
FIGO stage
IA	51 (46.8)
IB	33 (30.3)
II	8 (7.3)
IIIA	1 (0.9)
IIIB	1 (0.9)
IIIC	9 (8.3)
IVB	6 (5.5)
The histologic type of tumour
Endometrioid adenocarcinoma	90 (82.6)
Serous adenocarcinoma	9 (8.3)
Carcinosarcoma	10 (9.2)
Tumour differentiation grade
G1	38 (34.9)
G2	38 (34.9)
G3	28 (25.7)
Undetermined grade	5 (4.6)
Metastasis to regional lymph nodes
Yes	11 (10.1)
No	98 (89.9)
Lymphovascular invasion
Yes	18 (16.5)
No	91 (83.5)
Myometrial invasion
< 1/2	51 (46.8)
≥1/2	58 (53.2)
Menopausal status
Premenopausal	8 (7.3)
Postmenopausal	101 (92.7)
Body mass index
18.5–24.9	9 (8.3)
25.0–29.9	21 (19.3)
≥30	79 (72.5)